摘要 |
: The present invention is directed to compounds of the formula: wherein R is hydrogen, alkoxycarbonyl, benzyloxycarbonyl, heteroarylalkyl, phenylalkenyl, or -T-(Y)p-R6 (wherein T is a single bond or an alkylene group, Y is oxygen, sulfur or carbonyl, R6 is phenyl, substituted phenyl, naphthyl, or diphenylmethyl, and p is 0 or 1, provided that when T is a single bond, p is 0); R1 is halogen, hydroxy, alkoxy, cycloalkyloxy, alkenyloxy, alkynyloxy, alkoxy interrupted by oxygen or carbonyl, alkylthio, amino, monosubstituted amino, or a substituted alkoxy; R2 is hydrogen; R3 is hydrogen, halogen, amino, alkylamino, dialkylamino, alkanoylamino, or nitro; R4 is hydrogen, halogen, nitro, sulfamoyl, alkylsulfamoyl, or dialkylsulfamoyl; or any two adjacent groups of R1, R2, R3 and R4 may combine to form alkylenedioxy, and the remaining two groups are each hydrogen; R5 is hydrogen or alkyl; X is alkylene; m and n are each 1 or 2; provided that at least one of the groups R2, R3 and R4 is other than hydrogen, and acid addition salts, quaternary ammonium salts and N-oxide derivatives thereof, processes for their preparation, and pharmaceutical compositions containing the same. Said compounds, salts and N-oxide derivatives thereof show excellent gastroiotestinal motility enhancing activity. |
申请人 |
DAINIPPON PHARMACEUTICAL CO., LTD. |
发明人 |
KON, TATSUYA;KATO, SHIRO;MORIE, TOSHIYA;OHNO, KAZUNORI;HINO, KATSUHIKO;KARASAWA, TADAHIKO;YOSHIDA, NAOYUKI |